Ronan Flippot

2.8k total citations · 1 hit paper
80 papers, 1.3k citations indexed

About

Ronan Flippot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ronan Flippot has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 42 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Ronan Flippot's work include Renal cell carcinoma treatment (50 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Renal and related cancers (19 papers). Ronan Flippot is often cited by papers focused on Renal cell carcinoma treatment (50 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Renal and related cancers (19 papers). Ronan Flippot collaborates with scholars based in France, United States and Italy. Ronan Flippot's co-authors include Laurence Albigès, Bernard Escudier, Toni K. Choueiri, Laure Hirsch, Ziad Bakouny, David A. Braun, Eliezer M. Van Allen, Elie Rassy, Catherine J. Wu and Gabriel G. Malouf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ronan Flippot

76 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma

2021 224 citations David A. Braun, Ziad Bakouny et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronan Flippot France	18	826	630	567	412	196	80	1.3k
Rustem Gafanov Russia	17	1.2k 1.4×	846 1.3×	570 1.0×	438 1.1×	300 1.5×	49	1.4k
Dingwei Ye China	17	621 0.8×	417 0.7×	502 0.9×	286 0.7×	303 1.5×	88	1.2k
Luiz H. Araujo Brazil	13	597 0.7×	845 1.3×	446 0.8×	391 0.9×	124 0.6×	69	1.4k
Vesna Šneller United States	7	582 0.7×	360 0.6×	584 1.0×	361 0.9×	102 0.5×	12	995
Edward Arrowsmith United States	18	536 0.6×	623 1.0×	544 1.0×	234 0.6×	139 0.7×	60	1.2k
Amin H. Nassar United States	17	396 0.5×	454 0.7×	318 0.6×	216 0.5×	250 1.3×	74	886
Zachary R. Chalmers United States	15	580 0.7×	584 0.9×	649 1.1×	349 0.8×	152 0.8×	35	1.4k
Maria I. Carlo United States	21	1.2k 1.5×	695 1.1×	984 1.7×	591 1.4×	408 2.1×	83	1.9k
Yasir Y. Elamin United States	16	518 0.6×	595 0.9×	284 0.5×	164 0.4×	127 0.6×	68	968
Christopher Tretter United States	8	668 0.8×	429 0.7×	471 0.8×	381 0.9×	361 1.8×	12	1.1k

Countries citing papers authored by Ronan Flippot

Since Specialization

Citations

This map shows the geographic impact of Ronan Flippot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronan Flippot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronan Flippot more than expected).

Fields of papers citing papers by Ronan Flippot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronan Flippot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronan Flippot. The network helps show where Ronan Flippot may publish in the future.

Co-authorship network of co-authors of Ronan Flippot

This figure shows the co-authorship network connecting the top 25 collaborators of Ronan Flippot. A scholar is included among the top collaborators of Ronan Flippot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronan Flippot. Ronan Flippot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Négrier, Sylvie, Loı̈c Mourey, Ellen Blanc, et al.. (2025). Cabozantinib in patients (pts) with non-locally pretreated brain metastases (BM) from renal cell carcinoma (RCC): Results of the multicenter CABRAMET phase II trial (NCT03967522).. Journal of Clinical Oncology. 43(5_suppl). 533–533. 1 indexed citations

Flippot, Ronan, Marcus de Melo Teixeira, Lucía Carril-Ajuria, et al.. (2024). B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 12(4). e008636–e008636. 13 indexed citations

Albigès, Laurence, C. Suárez Rodríguez, Giuseppe Procopio, et al.. (2024). 1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma. Annals of Oncology. 35. S1029–S1029. 2 indexed citations

Guévelou, Jennifer Le, Francesco Cuccia, Ronan Flippot, et al.. (2024). The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 28(3). 546–556. 2 indexed citations

Rioux‐Leclercq, Nathalie, Maxime Meylan, Christophe Passot, et al.. (2023). Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 11(11). e006885–e006885. 8 indexed citations

Naigeon, Marie, Ronan Flippot, Cécile Dalban, et al.. (2023). 184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study. Immuno-Oncology Technology. 20. 100643–100643. 1 indexed citations

Bayle, Arnaud, Damien Vasseur, Claudio Nicotra, et al.. (2023). Clinical utility of plasma ctDNA sequencing in metastatic urothelial carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4576–4576. 1 indexed citations

Colomba, Émeline, Carolina Alves Costa Silva, Gwénaël Le Teuff, et al.. (2022). Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma. Journal of Cachexia Sarcopenia and Muscle. 13(5). 2405–2416. 8 indexed citations

McDermott, David F., Cristina Suárez, Thomas Powles, et al.. (2021). Checkpoint inhibitors in metastatic papillary renal cell carcinoma. Cancer Treatment Reviews. 99. 102228–102228. 17 indexed citations

10.

Dalban, Cécile, Brigitte Laguerre, Sylvain Ladoire, et al.. (2020). 712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial. Annals of Oncology. 31. S560–S561. 1 indexed citations

11.

McGregor, Bradley A., Michael S. Gordon, Ronan Flippot, et al.. (2020). Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma. Investigational New Drugs. 38(6). 1807–1814. 24 indexed citations

12.

Aldea, Mihaela, Luigi Cerbone, Pernelle Lavaud, et al.. (2020). 638P Meningeal metastases (MM) in patients with metastatic castration resistant prostate cancer (mCRPC). Annals of Oncology. 31. S525–S525. 3 indexed citations

13.

Cerbone, Luigi, Vincenzo Di Nunno, Ronan Flippot, et al.. (2020). 743P Activity of systemic therapies after cabozantinib (CABO) in patients (pts) with metastatic renal cell carcinoma (mRCC). Annals of Oncology. 31. S577–S577. 1 indexed citations

14.

Hirsch, Laure, Ronan Flippot, Bernard Escudier, & Laurence Albigès. (2020). Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma. Drugs. 80(12). 1169–1181. 69 indexed citations

15.

Nassar, Amin H., Lana Hamieh, Kathryn P. Gray, et al.. (2019). Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 690–696. 10 indexed citations

16.

Bakouny, Ziad, Ronan Flippot, David A. Braun, Aly‐Khan A. Lalani, & Toni K. Choueiri. (2019). State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy Era. European Urology Focus. 6(1). 37–40. 5 indexed citations

17.

Flippot, Ronan, et al.. (2019). Long non-coding RNAs in genitourinary malignancies: a whole new world. Nature Reviews Urology. 16(8). 484–504. 79 indexed citations

18.

Flippot, Ronan, Lisa Derosa, & Laurence Albigès. (2018). Les métastases cérébrales de cancer du rein, un défi clinique. Bulletin du Cancer. 105. S261–S267. 1 indexed citations

19.

Flippot, Ronan, Roger Mouawad, Morgan Rouprêt, et al.. (2017). Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma. Annals of Oncology. 28. v302–v303. 1 indexed citations

20.

Flippot, Ronan, Vincent Fallet, Benjamin Besse, et al.. (2015). Nivolumab, nouvel acteur majeur dans les cancers bronchiques non à petites cellules. Bulletin du Cancer. 102(12). 1046–1052. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact